EUVIMEDEUVIMED entdecken
Open Access

Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity

Jason S Rush, Joshua D Wertheimer, Steven D Goldberg, Donald Raymond, Mateusz Szuchnicki, Andrew J Baltus, Jeff Branson, Christopher F Stratton, Aaron N Patrick, Ruth Steele, Suraj Adhikary, Amanda Del Rosario und 15 weitere

Cell · 2026

DOI: 10.1016/j.cell.2025.12.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026. Verfasst von Jason S Rush und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: CARD Signaling Adaptor Proteins, Anti-Inflammatory Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Leona M and Harry B Helmsley Charitable Trust, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human genetic association studies highlight key genes involved in disease pathology, yet targets identified by these analyses often fall outside the traditional definitions of druggability. A rare truncated variant of the scaffold protein CARD9 is linked with protection from Crohn's disease, prompting us to pursue the development of inhibitors that might similarly modulate innate inflammatory responses. Using a phased approach, we first identified a ligandable site on CARD9 using a structurally diverse DNA-encoded library and defined this site in detail through X-ray crystallography. Building upon this, a subsequent ligand displacement screen identified additional molecules that uniquely engage CARD9 and prevent its assembly into scaffolds needed to nucleate a signalosome for downstream nuclear factor κB (NF-κB) induction. These inhibitors suppressed inflammatory cytokine production in dendritic cells and a humanized CARD9 mouse model. Collectively, this study illustrates a strategy for leveraging protective human genetic variants and chemical biology to tackle challenging targets for dampening inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CARD Signaling Adaptor ProteinsAnti-Inflammatory AgentsHumansAnimalsMiceCrystallography, X-RayDrug DiscoveryNF-kappa BCrohn DiseaseDendritic CellsInflammationModels, MolecularImmunity, Innate

Stichwörter der Autor:innen

Crohn's diseasebinder firstcoiled coildrug discoveryfungal immunityimmune-mediated diseaseinnate immunitysignalosomesmall molecule inhibitor

Substanzen

CARD Signaling Adaptor ProteinsCARD9 protein, humanAnti-Inflammatory AgentsNF-kappa B

Autor:innen und Institutionen

  • Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Johnson & Johnson Innovative Medicine, Spring House, PA 19477, USA.
  • Johnson & Johnson Innovative Medicine, San Diego, CA 92121, USA.
  • Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical Sch…
  • Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Bost…
  • Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA; Chemical Biology PhD…

Förderung

  • NIAID NIH HHS
  • Leona M and Harry B Helmsley Charitable Trust
  • National Institutes of Health

Zitieren

APA

Rush, J. S., Wertheimer, J. D., Goldberg, S. D., Raymond, D., Szuchnicki, M., Baltus, A. J., Branson, J., Stratton, C. F., Patrick, A. N., Steele, R., Adhikary, S., Del Rosario, A., Liu, A., Gomersall, N. J., Chung, M., Ranaghan, M. J., Gu, X., Brandt, M., Cao, Z., …, & Xavier, R. J. (2026). Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity. Cell. https://doi.org/10.1016/j.cell.2025.12.013

Vancouver

Rush JS, Wertheimer JD, Goldberg SD, Raymond D, Szuchnicki M, Baltus AJ, et al. Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity. Cell. 2026. doi:10.1016/j.cell.2025.12.013

BibTeX
@article{Rush2026,
  author = {Rush, Jason S and Wertheimer, Joshua D and Goldberg, Steven D and Raymond, Donald and Szuchnicki, Mateusz and Baltus, Andrew J and Branson, Jeff and Stratton, Christopher F and Patrick, Aaron N and Steele, Ruth and Adhikary, Suraj and Del Rosario, Amanda and Liu, Annie and Gomersall, Noah J and Chung, Michael and Ranaghan, Matthew J and Gu, Xiebin and Brandt, Marta and Cao, Zhifang and Bebenek, Adrian and Oliver, Blayne A and Hoebe, Kasper and Szewczuk, Lawrence M and Venable, Jennifer D and Graham, Daniel B and Towne, Jennifer and Xavier, Ramnik J},
  title = {Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity},
  journal = {Cell},
  year = {2026},
  doi = {10.1016/j.cell.2025.12.013}
}
Kostenlos starten →